In our previous experimental and clinical studies, TCM formula CP potently suppressed HBV-associated HCC by interfering with HBx-SHH pathway axis, inhibiting HBV-DNA replication and suppressing HBV-associated oncogenes (Tong et al., 2014; Li et al., 2019). Here, SHH is linked to hepatocellular carcinoma.